S*BIO Pte Ltd Company Profile

12:35 EDT 4th September 2015 | BioPortfolio

S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization.


News Articles [412571 Results]

Impax Laboratories Receives Form 483 Following FDA Inspection

FDA issues a Form 483 following inspection of Impax Laboratories' Hayward, CA facility. read more

Beyond the Crisis

First published in 1994, this volume discusses the nature of health care reform and the capacity for medical excellence within the context of such reform.

Science-Based Economic Development

Key elements in science-based development.

System for Synergistic Combination of Multiple Automatic Induction Methods and Automatic Re-Representation of Data

The present application describes a unique prototype of an advanced framework which relates to the field of multidimensional data mining, machine learning, and analysis that has been named COEV (for C...

Cannabinoids As Neuroprotectants

This technology describes the neuroprotective properties of cannabidiol(CBD), 2-[3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1yl]-5-pentyl-1,3-benzenediol. Cannabidiol is a neuroprotective cann...

Use of Constitutive Transport Elements to Control the Host Range of Retroviral Vectors

The major host range determinant for retroviruses and for retroviral vectors is the envelope glycoprotein. However there is a second element, the constitutive transport element, or CTE, that ...

Medical Ethics at the Dawn of the 21st Century

This volume takes a major step toward tackling medical ethics at the dawn of the 21st century.

Nexia, Inst. of Plant Genetics in transgenics deal

Nexia Biotechnologies (complex recombinant proteins) will collaborate with the Institute of Plant Genetics & Crop Plant Research (IPG) in developing a method for manufacturing spider silk proteins in ...

Clinical Trials [80979 Results]

The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery

Arnica montana is a homeopathic drug that is made in accordance with the official methods of the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic surg...

Pharyngeal Size in Patients With Obstructive Tonsils Under Orthodontic Treatment

Enlarged tonsils and malocclusion has relationship with sleep disturbance in children. The consequences of these features can include aggravation of craniofacial growth such that the devel...

The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response

The purpose of this study is to assess the effects of repeated RIPC and exercise, on exercise performance, skeletal muscle responses and circulating cellular and humoral biology in humans

Pilot Study of Raltegravir Lipodystrophy IISP

The substitution of raltegravir for the NRTIs will result in some reversal of the long term adverse effect of lipodystrophy (specifically peripheral lipoatrophy) that is associated with th...

Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy

Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient...

Companies [49351 Results]

Biogen Idec Inc.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Compugen Ltd.

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...

Schiff Nutrition International, Inc.

Schiff Nutrition International, Inc. develops, manufactures, markets and distributes branded and private label vitamins, nutritional supplements and nutrition bars in the United S...

Fero Industries, Inc.

Fero Industries, Inc. is a publicly traded holding company (OTC BB: FROI.OB). Fero’s mission is to acquire healthcare related companies, products, and technologies that have large market poten...

Water Pik, Inc.

Water Pik is a leading developer, manufacturer and marketer of innovative personal healthcare products sold under the Waterpik® brand name. The Company has developed and introd...

More Information about "S*BIO Pte Ltd" on BioPortfolio

We have published hundreds of S*BIO Pte Ltd news stories on BioPortfolio along with dozens of S*BIO Pte Ltd Clinical Trials and PubMed Articles about S*BIO Pte Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of S*BIO Pte Ltd Companies in our database. You can also find out about relevant S*BIO Pte Ltd Drugs and Medications on this site too.


Advertisement
 

Relevant Topics

Biotechnology - Biotech
Latest News Clinical Trials Research Drugs Reports Corporate
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer Disease
Latest News Clinical Trials Research Drugs Reports Corporate
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record